Blood Glucose Monitoring Devices Market Report 2026

Blood Glucose Monitoring Devices Market Overview

• Blood Glucose Monitoring Devices market size has reached to $19.08 billion in 2025 • Expected to grow to $30.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Rising Prevalence Of Diabetes Worldwide Fueling The Growth Of The Market Due To Increasing Need For Continuous Glucose Tracking And Disease Management • Market Trend: Advancements In Continuous Glucose Monitoring (CGM) Systems Improve Real Time Diabetes Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Blood Glucose Monitoring Devices Market?

Blood glucose monitoring devices are medical devices used to measure and monitor blood glucose levels in individuals with diabetes and other metabolic disorders. These devices help patients and healthcare providers track glucose fluctuations, manage treatment plans, and improve glycemic control through regular monitoring. The main product types of blood glucose monitoring devices include self monitoring blood glucose systems, continuous glucose monitoring systems, and professional point of care devices. Self monitoring blood glucose systems refer to portable devices that measure blood glucose levels from small blood samples, enabling individuals to monitor and manage glucose levels in routine care. These systems support testing at the fingertip, upper arm, and alternate sites and are used for diabetes management and health and wellness monitoring. The various applications involved are diabetes management and health and wellness monitoring and they are utilized by end users including self or home care and hospitals and clinics.

What Is The Blood Glucose Monitoring Devices Market Growth Forecast?

The blood glucose monitoring devices market size is expected to see strong growth in the next few years. It will grow to $30.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing demand for continuous glucose monitoring, increasing adoption of home healthcare, rising focus on preventive healthcare, expanding reimbursement support for diabetes care, increasing incidence of obesity and metabolic disorders. Major trends in the forecast period include growing adoption of continuous glucose monitoring systems, increasing preference for non invasive glucose monitoring technologies, rising demand for personalized diabetes management, expansion of home based blood glucose monitoring, greater focus on early detection and glycemic control.

What Is The Driver Of The Blood Glucose Monitoring Devices Market?

The rising prevalence of diabetes worldwide is expected to propel the growth of the blood glucose monitoring devices market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from insufficient insulin production, impaired insulin action, or both. The rising prevalence of diabetes is due to increasing obesity rates, which significantly increase the risk of developing type 2 diabetes. Blood glucose monitoring devices support diabetes management by enabling continuous glucose tracking, facilitating timely treatment adjustments, and reducing the risk of severe health complications. For instance, in March 2025, according to the UK Health Security Agency, a UK-based government public health organization, the GP-recorded prevalence of type 2 diabetes among adults aged 17 years and older in England increased from 6.8% in March 2023 to 7.0% in March 2024, representing an increase of approximately 2.9%. Therefore, the rising prevalence of diabetes worldwide is driving the growth of the blood glucose monitoring devices industry.

Key Players In The Global Blood Glucose Monitoring Devices Market

Major companies operating in the blood glucose monitoring devices market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic plc, DexCom Inc., LifeScan Inc., Ascensia Diabetes Care Holdings AG, Sinocare Inc., Arkray Inc., Nova Biomedical Corporation, TaiDoc Technology Corporation, i-SENS Inc., ACON Laboratories Inc., Bionime Corporation, Apex Biotechnology Corporation, OSANG Healthcare Co. Ltd., OK Biotech Co. Ltd., ALL MEDICUS Co. Ltd., Senseonics Holdings Inc., Biolinq Incorporated, GlucoTrack Inc., Know Labs Inc., Afon Technology Ltd.

Global Blood Glucose Monitoring Devices Market Trends and Insights

Major companies operating in the blood glucose monitoring devices market are focusing on developing advanced products such as continuous glucose monitoring (CGM) systems to provide real-time glucose tracking, improve diabetes management, enhance patient convenience, and support better clinical outcomes. Continuous glucose monitoring (CGM) systems are wearable medical devices that continuously measure glucose levels in interstitial fluid and provide real-time glucose data, trends, and alerts to help individuals manage diabetes more effectively. For instance, in February 2023, Dexcom, a US-based medical device company, launched the Dexcom G7, a continuous glucose monitoring system. The device features a 30-minute sensor warm-up period, an all-in-one wearable sensor and transmitter design, and enhanced accuracy with a Mean Absolute Relative Difference (MARD) of approximately 8.2%. The system also enables real-time glucose sharing with caregivers and integrates with compatible digital health platforms, improving diabetes management efficiency.

What Are Latest Mergers And Acquisitions In The Blood Glucose Monitoring Devices Market?

In August 2024, Abbott, a US-based manufacturer of continuous glucose monitors, partnered with Medtronic plc to integrate Abbott's continuous glucose monitoring technology with Medtronic's insulin delivery systems to deliver more connected and personalized diabetes management. The partnership aims to improve blood glucose monitoring and insulin therapy by expanding interoperability between continuous glucose monitoring devices and automated insulin delivery systems for people with diabetes. Medtronic plc is an Ireland-based medical device company.

What Defines the Blood Glucose Monitoring Devices Market?

The blood glucose monitoring devices market consists of sales of blood glucose test strips, lancets, lancing devices, and blood glucose sensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Blood Glucose Monitoring Devices Market Report 2026?

The blood glucose monitoring devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.